WP
ABCL icon

Woodline Partners’s AbCellera Biologics ABCL Stock Holding History

Woodline Partners’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,163
Closed -$36K – 587
2024
Q2 		$36K Buy
+12,163
New +$46K ﹤0.01% 544
2022
Q2 		– Sell
-136,910
Closed -$1.33M – 793
2022
Q1 		$1.33M Sell
136,910
-533,729
-80% -$5.05M 0.02% 447
2021
Q4 		$9.59M Buy
670,639
+273,823
+69% +$4.16M 0.14% 206
2021
Q3 		$7.95M Hold
396,816
– – 0.13% 190
2021
Q2 		$8.73M Buy
396,816
+141,914
+56% +$3.91M 0.16% 148
2021
Q1 		$8.66M Sell
254,902
-176,185
-41% -$7.02M 0.19% 137
2020
Q4 		$17.3M Buy
+431,087
New +$19.7M 0.46% 69

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return